白癜风发病机制研究进展-周晖

[e-mail]··510080。、－、、、。。R758．4+1A1674－8468201202－0111－03vitiligo、。0.5%～1%1。、－、、。。1。6.25%～40%182。。3、、。3。2－、、、4。。2．1TNF-α、IL-1β、IL-6、IL-85-67Th1789。、10-119。2．2。50%～93%1112012419212CD8+TT4。“”“”1－。3、、13。67－。reactiveoxygenspeciesROS14。－ROS1。44．1dUTPTdT-mediateddUTPnickendlabelingTUNELSmyth15。B－2B-celllymphoma2Bcl-2Bcl-2。16。。4．2melanocytorrhagy24、。、17。Koebner“”“”。5、、。、、、18。。19。19。。1GuerraLDellambraEBresciaSetal．Vitiligopatho-211JDiagnTherDermato-VenereolApr．2012．Vol．19No．2genetichypothesesandtargetsforcurrenttherapiesJ．CurrDrugMetab2010115451-467．2SehgalVNSrivastavaG．Vitiligocompendiumofclini-co-epidemiologicalfeaturesJ．IndianJDermatolVene-reolLeprol2007733149-156．3SpritzRA．RecentprogressinthegeneticsofgeneralizedvitiligoJ．JGenetGenomics2011387271-278．4LePooleICLuitenRM．Autoimmuneetiologyofgener-alizedvitiligoJ．CurrDirAutoimmun200810227-243．5KimNHTorchiaDRouhaniPetal．Tumornecrosisfactor-alphainvitiligodirectcorrelationbetweentissuelevelsandclinicalparametersJ．CutanOculToxicol2011303225-227．6BirolAKisaUKurtipekGSetal．IncreasedtumornecrosisfactoralphaTNF-alphaandinterleukin1al-phaIL1-alphalevelsinthelesionalskinofpatientswithnonsegmentalvitiligoJ．IntJDermatol2006458992-993．7KotobukiYTanemuraAYangLetal．DysregulationofmelanocytefunctionbyTh17-relatedcytokinessignifi-canceofTh17cellinfiltrationinautoimmunevitiligovul-garisJ．PigmentCellMelanomaRes2012252219-230．8WangCQCruz-InigoAEFuentes-DuculanJetal．Th17cellsandactivateddendriticcellsareincreasedinvitiligolesionsJ．PLoSOne201164e18907．9TaiebA．VitiligoasaninflammatoryskindisorderatherapeuticperspectiveJ．PigmentCellMelanomaRes20122519-13．10ParsadDKanwarA．Oralminocyclineinthetreatmentofvitiligo———apreliminarystudyJ．DermatolTher2010233305-307．11ZailaieM．Aspirinreducesserumanti-melanocyteanti-bodiesandsolubleinterleukin-2receptorsinvitiligopa-tientsJ．SaudiMedJ20052671085-1091．12KempEHGavalasNGGawkrodgerDJetal．Autoanti-bodyresponsestomelanocytesinthedepigmentingskindiseasevitiligoJ．AutoimmunRev200763138-142．13GlassmanSJ．VitiligoreactiveoxygenspeciesandT-cellsJ．ClinSciLond2011120399-120．14Dell’AnnaMLOttavianiMAlbanesiVetal．Mem-branelipidalterationsasapossiblebasisformelanocytedegenerationinvitiligoJ．JInvestDermatol200712751226-1233．15WangXErfGF．ApoptosisinfeathersofSmythlinechickenswithautoimmunevitiligoJ．JAutoimmun200422121-30．16MorettiSFabbriPBaroniGetal．Keratinocytedys-functioninvitiligoepidermiscytokinemicroenvironmentandcorrelationtokeratinocyteapoptosisJ．HistolHis-topathol2009247849-857．17KumarRParsadDKanwarAJ．Roleofapoptosisandmelanocytorrhagyacomparativestudyofmelanocytead-hesioninstableandunstablevitiligoJ．BrJDermatol20111641187-191．18LanWJWangHYWeiLetal．Evidencethatgenipo-sideabrogatesnorepinephrine-inducedhypopigmentationbytheactivationofGLP-1R-dependentc-kitreceptorsig-nalinginmelanocyteJ．JEthnopharmacol20081181154-158．19SchallreuterKUBahadoranPPicardoMetal．Vitiligopathogenesisautoimmunediseasegeneticdefectexces-sivereactiveoxygenspeciescalciumimbalanceorwhatelseJExpDermatol2008172139-140141-160．2011－09－29櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆櫆2012－03－15、20119《2011》0．46。。、31120124192